Welcome to our dedicated page for 180 Life Sciences news (Ticker: ATNF), a resource for investors and traders seeking the latest updates and insights on 180 Life Sciences stock.
180 Life Sciences Corp (ATNF) is a clinical-stage biotechnology company pioneering treatments for inflammatory diseases, fibrosis, and pain through advanced therapeutic platforms. This page serves as the definitive source for official news and developments across the company’s scientific research and blockchain-enabled iGaming initiatives.
Investors and industry observers will find timely updates on clinical trial progress, regulatory milestones, financial announcements, and strategic partnerships. Key focus areas include the company’s anti-TNF fibrosis research, synthetic cannabidiol analogs development, and expansion into blockchain-based gaming technology solutions.
All content is curated to provide accurate, compliance-focused information without speculative commentary. Regular updates ensure stakeholders maintain current awareness of ATNF’s progress in both biotechnology and digital innovation sectors.
Bookmark this page for direct access to press releases, earnings reports, and operational updates from 180 Life Sciences Corp. Check back frequently for the latest developments shaping this innovative dual-sector enterprise.
180 Life Sciences Corp. (NASDAQ: ATNF) announced the closing of its registered direct offering, selling 1,570,680 shares of common stock and warrants, generating approximately $3 million in gross proceeds. The shares were priced at $1.91 each, with warrants allowing purchase at $1.78. The net proceeds will fund research and development expenses, including a marketing authorization application.
A.G.P./Alliance Global Partners acted as the placement agent. The offering is based on an effective shelf registration statement with the SEC filed previously. Additionally, existing warrants for 2,878,032 shares will be amended to lower the exercise price to $1.78 and extend the expiration.
FAQ
What is the current stock price of 180 Life Sciences (ATNF)?
What is the market cap of 180 Life Sciences (ATNF)?
